Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Transplant;Failure,Kidney: later-stage trial registry
4 of 9 indexed Transplant;Failure,Kidney trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Transplant;Failure,Kidney: 9 US clinical trials tracked, 4 recruiting.
Transplant;Failure,Kidney is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Davis, running 2 of these trials.
Enrollment posture brief
Registry condition transplantfailurekidney
OPEN 4 | RECR 44% | LATE 3 | EARLY 1 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)
Transplant;Failure,Kidney lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Transplant;Failure,Kidney on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Transplant;Failure,Kidney is recruiting below its size-band peers.
4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Transplant;Failure,Kidney research.
University of California, Davis accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Transplant;Failure,Kidney enrolment sits around 65 participants.
Median target enrolment is 65 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.
-
Transplant;Failure,Kidney research is mostly interventional.
8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
University of California, Davis
NCT03737604
Dietary Intervention to Improve Kidney Transplant Outcomes
University of California, Davis
NCT05449496
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
Johns Hopkins University
NCT05613010
Abdominal Wall Transplant
Duke University
NCT03310905
Quality of Life in Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients
Northwestern University
NCT00856895
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
Stanley Jordan, MD
NCT03380962
Oral Paricalcitol in Kidney Transplant Recipients
Mayo Clinic
NCT00587158
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Sentara Norfolk General Hospital
NCT03760263
Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)
East Carolina University
NCT01044303
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Transplant;Failure,Kidney records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Transplant;Failure,Kidney trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Transplant;Failure,Kidney page
9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Transplant;Failure,Kidney trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of California, Davis sponsors the most Transplant;Failure,Kidney trials on record, review their full trial history before evaluating a specific study. See University of California, Davis's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Transplant;Failure,Kidney condition card totals 9 registered trials; most-linked intervention Corticosteroid Avoidance Immune Suppression Protocol; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.